Clinical Trials Directory

Trials / Unknown

UnknownNCT05800626

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

Prediction of Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis Based on the Appearance of the Major Duodenal Papilla: a Prospective, Observational, Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,740 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This observational, prospective study aims at evaluating how the occurrence of post-Endoscopic Retrograde CholangioPancreatography (ERCP) acute pancreatitis (PEP) could be influenced by difficult biliary cannulation that might be previously assessed by the morphological appearance of native major papilla in all the patients undergoing ERCP. The rate of successful biliary cannulation across papilla types could be used as intraprocedural quality and competence metrics during training. Moreover, recognizing difficult papillae could allow reserving those to experts to decrease the odds of failed cannulation.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Retrograde Cholangio-Pancreatography (ERCP)ERCP performed for clinical practice

Timeline

Start date
2023-04-01
Primary completion
2025-04-01
Completion
2025-12-31
First posted
2023-04-05
Last updated
2024-02-28

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05800626. Inclusion in this directory is not an endorsement.